CNS clinical trials : suicidality and data collection : workshop summary

CNS clinical trials suicidality and data collection : workshop summary

Mostrar otras versiones (1)

"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience...

Descripción completa

Detalles Bibliográficos
Autor principal: Hanson, Sarah (-)
Autores Corporativos: Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders (-), National Academies Press (U.S.)
Otros Autores: Davis, Miriam, Altevogt, Bruce M.
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2010.
Edición:1st ed
Materias:
Suicide > Risk factors.
Suicide > Prevention.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622373806719
Tabla de Contenidos:
  • Perspectives from the FDA, academia, and patients
  • Data collection and optimization
  • Data analysis
  • Partnerships, opportunities, collaboration.

Ejemplares similares